Ontario man wins OHIP battle for US cancer therapy
Alex Shved, an Ontario man with Stage 4 melanoma, is fighting for public funding for a $600,000 life-saving cancer treatment in the U.S. Despite a court ruling in his favor, Ontario health officials have denied his request following a change in provincial funding regulations.
Why it matters
This case highlights the tension between individual patient rights and government healthcare policy regarding experimental or out-of-country treatments.
An Ontario man with Stage 4 melanoma who successfully challenged the province in court over access to potentially life-saving cancer treatment says he is now “incredibly disappointed and disheartened” after Ontario changed the rules governing public funding for out-of-country drug treatments.According to CBC News, Alex Shved, 37, took the province to court after the Ontario Health Insurance Plan rejected his oncologist’s request for him to receive tumour-infiltrating lymphocyte therapy, or TIL therapy, in the United States.Shved, a father of two young daughters, has cancer that has spread to his lungs and bones.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in